ArticleMolecular pharmacology2009

Bezafibrate at clinically relevant doses decreases serum/liver triglycerides via down-regulation of sterol regulatory element-binding protein-1c in mice: a novel peroxisome proliferator-activated receptor alpha-independent mechanism.

Takero Nakajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.